A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials

INTRODUCTION: Over the past decade, the potential for drug-associated progressive multifocal leukoencephalopathy (PML) has become an increasingly important consideration in certain drug development programmes, particularly those of immunomodulatory biologics. Whether the risk of PML with an investig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Saf
Main Authors: Parikh, Asit, Stephens, Kristin, Major, Eugene, Fox, Irving, Milch, Catherine, Sankoh, Serap, Lev, Michael H., Provenzale, James M., Shick, Jesse, Patti, Mark, McAuliffe, Megan, Berger, Joseph R., Clifford, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6061428/
https://ncbi.nlm.nih.gov/pubmed/29737503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-018-0669-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados